Registration - In-house Corporation

Tilray Inc. / Brendan Kennedy, Chief Executive Officer

Registration Information

In-house Corporation name: Tilray Inc.
Previous in-house corporation names
Responsible Officer Name: Brendan Kennedy, Chief Executive Officer
Initial registration start date: 2016-10-13
Registration status: Inactive
Registration Number: 928606-358619

Associated Communications

Total Number of Communication Reports: 63

Monthly communication reports in the last 6 months: 0

Version 9 of 17 (2017-10-02 to 2018-01-17)

Registration versions:

Version 9 of 17 (2017-10-02 to 2018-01-17)

Lobbying Information

Subject Matters

Aboriginal Affairs
Agriculture
Consumer Issues
Economic Development
Health
Industry
International Trade
Justice and Law Enforcement
Regional Development
Research and Development
Science and Technology
Taxation and Finance

Subject Matter Details

Grant, Contribution or Other Financial Benefit

To advocate for investment from the government into medical cannabis production expansion in key regions and the resulting job creation.

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Advocacy related to Bill C-45, "An Act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts" to advocate for a strong, well-regulated recreational cannabis system that allows for limited branding/in-store promotion and fair taxation for legal cannabis producers while meeting the federal goals of keeping cannabis out of the hands of children, eradicating the black market, minimizing harms of use, ensuring Canadians are well-informed about responsible use and, establishing and enforcing a system of strict production and distribution while continuing to provide medical cannabis to patients in need.
Advocacy related to Bill C-46, "An Act to amend the Criminal Code (offences relating to conveyances) and to make consequential amendments to other Acts", to ensure that provisions contained in the legislation protect the public health of Canadians, including active medical cannabis patients.

Policies or Program

Advocacy related to the development of an export strategy for medical cannabis to ensure that Canada's licensed producers are able to seize first-mover advantage in international medical cannabis markets.

Communication Techniques

Written communication
Oral communication
Grass-roots communication

Government Institutions

Agriculture and Agri-Food Canada (AAFC)
Canada Revenue Agency (CRA)
Canadian Heritage (PCH)
Employment and Social Development Canada (ESDC)
Farm Credit Canada (FCC)
Federal Economic Development Agency for Southern Ontario (FedDev)
Finance Canada (FIN)
Global Affairs Canada (GAC)
Health Canada (HC)
House of Commons
Indigenous and Northern Affairs Canada
Innovation, Science and Economic Development Canada (ISED)
Justice Canada (JC)
Prime Minister's Office (PMO)
Privy Council Office (PCO)
Public Safety Canada (PS)
Senate of Canada
Treasury Board Of Canada Secretariat (TBS)
Veterans Affairs Canada (VAC)
Western Economic Diversification Canada (WD)

In-house Corporation Details

Description of activities

Privateer Holdings is a private equity firm focused on the future of the legal cannabis industry. Through a combination of acquisitions, investments and incubation, we are building a portfolio of global brands that will lead, legitimize and define the future of cannabis.

Responsible officer name and position during the period of this registration

Brendan Kennedy, Chief Executive Officer

Government funding

No government funding was received during the last completed financial year.

In-house Corporation Contact Information

Address:
1920 Eastlake Avenue E
Seattle, WA 98102
United States of America

Telephone number: 415-534-5541

Parent Company Information

Privateer Holdings is not a subsidiary of any other parent companies.

Subsidiary Beneficiary Information

Leafly
- 71 Columbia Street
  Suite 300
  Seattle, WA 98104
  United States of America
Marley Natural
- 149 Bowery
  New York, NY 10002
  United States of America
Tilray
- 1100 Maughan Road
  Nanaimo, BC V9X 1J2
  Canada

Lobbyists Details

Senior Officers whose lobbying activities represent less than 20% of their Duties

Caleb Eades, Chief Science Officer & Vice President | No public offices held
Zack Hutson, Vice President of Corporate Affairs | No public offices held
Brendan Kennedy, Chief Executive Officer | No public offices held
Woody Pastorius, President, Tilray North America | No public offices held
Christy Zhou, General Counsel (Tilray) | No public offices held

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties

Cameron Bishop, Director of Government Affairs | Public offices held

Tilray Inc.

The following names have been used on or after July 2, 2008

Name	From	To
Tilray Inc.	2018-07-25	2021-05-01
Privateer Holdings	2016-10-13	2018-07-25

Tilray Inc.

Responsible Officer History
Responsible Officer Name	From (YYYY-MM-DD)	To (YYYY-MM-DD)

List of Public Offices Held
Position	Period Held	Last Date Designated Public Office Held
Press Secretary Health Canada, Office of the Minister of Public Health	January 2005 to February 2006	Not a designated office

Date Modified:: 2025-04-30

Search and menus

Language selection

Registration - In-house Corporation

Tilray Inc. / Brendan Kennedy, Chief Executive Officer

Registration Information

Associated Communications

Version 9 of 17 (2017-10-02 to 2018-01-17)

Version 9 of 17 (2017-10-02 to 2018-01-17)

Subject Matters

Subject Matter Details

Grant, Contribution or Other Financial Benefit

Legislative Proposal, Bill or Resolution, Policies or Program, Regulation

Policies or Program

Communication Techniques

Government Institutions

Description of activities

Responsible officer name and position during the period of this registration

Government funding

In-house Corporation Contact Information

Parent Company Information

Subsidiary Beneficiary Information

Senior Officers whose lobbying activities represent less than 20% of their Duties

Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties